fromwww.theguardian.com1 month agoUS politicsAstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats
fromLondon Business News | Londonlovesbusiness.com1 month agoUK newsNorman Lamont warns AstraZenaca quitting London Stock Exchange will be a 'devastating blow'
fromwww.theguardian.com1 month agoUS politicsAstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats
fromLondon Business News | Londonlovesbusiness.com1 month agoUK newsNorman Lamont warns AstraZenaca quitting London Stock Exchange will be a 'devastating blow'
European startupsfromFast Company3 months agoTrump's drug pricing order puts Roche's $50 billion U.S. investment plans at riskTrump's drug pricing executive order risks Roche's $50 billion investment in the U.S.